Eikon Therapeutics

Verified by our team

  • Research
Linkedin Twitter Facebook

Eikon Therapeutics is a pioneering biopharmaceutical company using groundbreaking microscopy technology to advance drug discovery. By directly measuring protein movement in living cells, Eikon uncovers novel drug targets and enables the creation of life-saving therapies for life-threatening diseases.

Eikon Therapeutics Highlights:

  • Eikon Therapeutics annual revenue is $5.6M.
  • Eikon Therapeutics total funding is $668.0M.
  • Eikon Therapeutics headquartered in Hayward, California.
  • Eikon Therapeutics number of employees is 380.

    • Overview

    • Website: eikontx.com
    • Headquarters: Hayward, California
    • Employees: 380
    • Founded: 2019
    • Email: saereporting@eikontx.com
    • Funding: $668.0M
    • Revenue: $5.6M
    • Valuation: n/a

    Contacts

    Roger P

    CEO
    Linkedin
    • Email: ***@eikontx.com
    Buy the List to Unlock Contacts

    Similar companies

    Frequently Asked Questions related to Eikon Therapeutics

    Eikon Therapeutics is located in Hayward, California.
    Yes, Eikon Therapeutics is a Silicon Valley company.
    Eikon Therapeutics total funding is 668.0M.
    Eikon Therapeutics revenue is 5.6M.
    Eikon Therapeutics’s number of employees is 380.
    Eikon Therapeutics’s CEO name is Roger P.
    Eikon Therapeutics was founded in 2019.
    Eikon Therapeutics’s contact email is saereporting@eikontx.com.

    Follow Silicon Valley Journals

    Awarded by

    corporate vision magazine

    © Copyright 2022-2024 Silicon Valley Journals. All rights reserved.

    Fundings

    Quick links

    Company

    © Copyright SVJ Media Ltd., 71-75 Shelton Street. Covent Garden. London, GB WC2H 9JQ